medical emblem

FDA Warnings on High Dosages of Acetaminophen

The FDA is asking doctors to stop prescribing combination medications that contain more than 325 milligrams of acetaminophen per pill, because of long-standing concerns about liver damage. The move, announced Tuesday, is one of a series of actions the FDA is taking to limit high-dose use of the popular painkiller….

Meningitis Death Toll at 15 – Company Under Intense Scrutiny

Meningitis Death Toll at 15 – Company Under Intense Scrutiny

Federal Agents from the Food and Drug Administration raided the NECC (New England Compounding Center) which is linked to the recent outbreak of meningitis in several states. Fifteen are dead and hundreds sickened. Read the following article from Reuters’ Greg McCune as news floods the media about this serious health…

Regulation Advised for Compounding of Drugs

Regulation Advised for Compounding of Drugs

Some local pharmacies offer compounding services to meet special needs of patients. However, some pharmacies are acting as miniature drug companies replicating products already available on the market to compete with large pharmaceutical companies. This has created an element of risk that is talked about in this Editorial from the…

Victory for Big Pharma: Texas Adopts “Learned Intermediary” Rule

Big Pharma had a major victory on June 8th, when the Texas Supreme Court handed down its ruling in Centocor, Inc. v. Hamilton.  The Court held that “When a drug manufacturer properly warns a prescribing physician of the dangerous propensities of its product, the manufacturer is excused from warning each…

Depakote Maker to pay $1.5 Billion to Settle Criminal and Civil Investigations

Last week, the Department of Justice Announced a record $1.5 Billion settlement with Abbott Laboratories over their mislabeling of the drug Depakote. “Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful…

The Risks of Using Generic Drugs

The Risks of Using Generic Drugs

by Sarah Hoffman, SpringerLyle ••• In June of 2011, the United States Supreme Court decided an important issue regarding the warning labels on prescription drugs in Pliva, Inc. et al v. Mensing.  Mensing was a prescription drug failure-to-warn-case.  It dealt with prescription drug companies’ failure to put accurate warnings on…

Hip Implant Complaints Increase, While Dangers Are Reviewed

Hip Implant Complaints Increase, While Dangers Are Reviewed

By BARRY MEIER and JANET ROBERTS of the New York Times Published: August 22, 2011 The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health…

Voluntary Recall Of Slimming Capsules

Voluntary Recall Of Slimming Capsules

from the U.S. Food and Drug Administration website**: Intercharm Inc. Issues A Nationwide Voluntary Recall Of Slim Forte Slimming Capsules Lot 20100604 And Lot 20100928, Slim Forte Slimming Coffee Lot 20100903, And Meizitang Botanical Slimming Softgel Exp. 12.23.2011 Weight Loss Capsules Found To Contain Sibutramine Contact: Intercharm Inc. 323-876-7441 FOR…